Prenetics Global Ltd - Asset Resilience Ratio
Prenetics Global Ltd (PRE) has an Asset Resilience Ratio of 5.32% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Prenetics Global Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2024)
This chart shows how Prenetics Global Ltd's Asset Resilience Ratio has changed over time. See PRE net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Prenetics Global Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Prenetics Global Ltd market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $10.46 Million | 5.32% |
| Total Liquid Assets | $10.46 Million | 5.32% |
Asset Resilience Insights
- Limited Liquidity: Prenetics Global Ltd maintains only 5.32% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Prenetics Global Ltd Industry Peers by Asset Resilience Ratio
Compare Prenetics Global Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Eurofins-Cerep SA
PA:ALECR |
Diagnostics & Research | 6.56% |
|
Inoviq Ltd
AU:IIQ |
Diagnostics & Research | 56.29% |
|
Bcal Diagnostics Ltd
AU:BDX |
Diagnostics & Research | 0.00% |
|
Imagion Biosystems Ltd
AU:IBX |
Diagnostics & Research | 150.16% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
|
Monash Ivf Group Ltd
AU:MVF |
Diagnostics & Research | 1.60% |
Annual Asset Resilience Ratio for Prenetics Global Ltd (2000–2024)
The table below shows the annual Asset Resilience Ratio data for Prenetics Global Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 4.95% | $10.56 Million | $213.57 Million | -5.69pp |
| 2023-12-31 | 10.64% | $27.03 Million | $254.17 Million | -1.36pp |
| 2022-12-31 | 12.00% | $37.46 Million | $312.13 Million | +5.33pp |
| 2021-12-31 | 6.67% | $9.91 Million | $148.51 Million | +6.27pp |
| 2020-12-31 | 0.40% | $314.71K | $78.88 Million | -0.59pp |
| 2019-12-31 | 0.99% | $294.06K | $29.69 Million | -1.95pp |
| 2015-12-31 | 2.94% | $629.10 Million | $21.41 Billion | +1.19pp |
| 2014-12-31 | 1.75% | $390.08 Million | $22.27 Billion | -0.28pp |
| 2013-12-31 | 2.03% | $467.00 Million | $23.04 Billion | -3.26pp |
| 2012-12-31 | 5.28% | $1.21 Billion | $22.98 Billion | +1.79pp |
| 2011-12-31 | 3.49% | $798.35 Million | $22.86 Billion | -1.72pp |
| 2010-12-31 | 5.22% | $1.22 Billion | $23.36 Billion | +0.03pp |
| 2009-12-31 | 5.18% | $1.23 Billion | $23.73 Billion | +1.83pp |
| 2008-12-31 | 3.35% | $545.01 Million | $16.28 Billion | -3.09pp |
| 2007-12-31 | 6.44% | $1.03 Billion | $16.04 Billion | -3.25pp |
| 2006-12-31 | 9.69% | $1.45 Billion | $14.95 Billion | +2.67pp |
| 2005-12-31 | 7.02% | $965.21 Million | $13.74 Billion | +2.63pp |
| 2004-12-31 | 4.39% | $549.30 Million | $12.51 Billion | +0.17pp |
| 2003-12-31 | 4.22% | $460.08 Million | $10.90 Billion | -1.22pp |
| 2002-12-31 | 5.44% | $474.97 Million | $8.74 Billion | +2.50pp |
| 2001-12-31 | 2.93% | $210.15 Million | $7.17 Billion | +1.61pp |
| 2000-12-31 | 1.32% | $80.44 Million | $6.09 Billion | -- |
About Prenetics Global Ltd
Prenetics Global Limited, a health sciences company, focuses on advancing consumer health in Hong Kong, the United States, and internationally. It sells health and wellness products under the IM8 brand name; and provides fulfillment and distribution services for sports nutrition products under the Europa brand. The company is also involved in the operation of CircleDNA, a consumer genetic testing… Read more